Merck Serono and MSM Protein Technologies Establish Drug Discovery Collaboration

News   Aug 04, 2009

 
Merck Serono and MSM Protein Technologies Establish Drug Discovery Collaboration
 
 
 

RELATED ARTICLES

XenoGesis and BioAscent Forge Alliance to Offer Enhanced Integrated Drug Discovery Services

News

XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services, including medicinal chemistry, biology and DMPK.

READ MORE

BioAscent Establishes Integrated Drug Discovery Services Offering

News

Dr Phil Jones to join as new CSO to lead company’s extended capabilities in medicinal chemistry and in vitro biosciences.

READ MORE

Lab Innovations returns to the NEC, Bimingham , UK

News

Save the date for the UK’s only lab-dedicated exhibition showcase!

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE